David C. Klonoff - Concepedia

Author

David C. Klonoff

Also Known As

Anusha Sultan Meo, Athena Philis-Tsimikas, Christopher Case, D C Klonoff, D. C. Klonoff, D. Klonoff, D.C. Klonoff, DAVID C. KLONOFF, David C Klonoff, David C. Klonoff

421

Publications

13.4K

Citations

H-Index

166

Concepts

All Affiliations

Mills Peninsula Health Services Diabetes Technology Society University of California, San Francisco Stanford University Sansum Diabetes Research Institute

About

David C. Klonoff is an author at Mills Peninsula Health Services specializing in diabetes, medicine, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	34	2.2K
2	Engineering	13	16	591
3	Education	6	6	200
4	Health Sciences	4	4	392
5	Language Studies	1	1	53

David C. Klonoff

108

Publications

7.3K

Citations

H-Index

Page 1

	Year	Citations
Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years David C. Klonoff, John B. Buse, Loretta L. Nielsen, Current Medical Research and Opinion	2007	698
Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia Richard M. Bergenstal, David C. Klonoff, Satish K. Garg, New England Journal of Medicine	2013	648
COVID-19 Pandemic: Impact of Quarantine on Medical Students’ Mental Wellbeing and Learning Behaviors Sultan Ayoub Meo, Abdulelah Adnan Abukhalaf, Ali Abdullah Alomar, Pakistan Journal of Medical Sciences	2020	311
Recommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile (AGP) Richard M. Bergenstal, Andrew Ahmann, Timothy S. Bailey, Diabetes Technology & Therapeutics	2013	294
Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: An interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials John B. Buse, David C. Klonoff, Loretta L. Nielsen, Clinical Therapeutics ObesityMetabolic SyndromeInterim AnalysisDiabetes ManagementBody Composition	2007	278
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings David C. Klonoff, Jing Wang, David Rodbard, Journal of Diabetes Science and Technology	2022	254
Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics. Sultan Ayoub Meo, Anna Meo, F F Al-Jassir, PubMed	2021	232
Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years David C. Klonoff, John B. Buse, Loretta L. Nielsen, Current Medical Research and Opinion ObesityMetabolic SyndromeDiabetes ManagementCardiovascular DiseaseDiabetes	2008	227
Continuous Glucose Monitoring: An Endocrine Society Clinical Practice Guideline David C. Klonoff, Bruce A. Buckingham, Jens Sandahl Christiansen, The Journal of Clinical Endocrinology & Metabolism	2011	213
The Surveillance Error Grid David C. Klonoff, Courtney Lias, Robert A. Vigersky, Journal of Diabetes Science and Technology	2014	164

Page 1